In the rapidly evolving field of biologic treatments, it's vital for patients to be aware of the regulatory landscape. Since June 2021, the FDA has set guidelines to ensure the safety and efficacy of biologic products.
Continuing our exploration of biologic injections, let's delve into some more essential considerations to ensure the effectiveness of your treatment.
Biologics have emerged as a promising avenue for treating various musculoskeletal issues, but it's crucial to ensure that the clinician administering these therapies is well-versed and up-to-date.
There is a lot of information in circulation about biologics and their respective treatment options. Here we’ll outline a few of the most important takeaways from this article series.
To see lasting effects from treatment using biologics—or more specifically Platelet-Rich Plasma (PRP) injections—we can’t overlook the importance of exercise.
While biologics have shown promise as treatments for musculoskeletal conditions, it's essential to be mindful of the challenges surrounding these therapies.
Platelet-Rich Plasma (PRP) has gained significant attention as a nonoperative regenerative treatment for a broad spectrum of musculoskeletal conditions. In this article, we will delve into the intricacies of PRP and its potential in promoting …
The biologics discussed in this article series are often clumped together under the umbrella term “Regenerative Medicine” which refers to the process of “regenerating” cells, tissues, or organs in order to restore them to …
Our current knowledge of biologics is based on many years of research and on what the Federal Food and Drug Administration policies will allow.
Ready to schedule your first appointment?